Resumen: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by pruritus, eczematous lesions, and lichenification. Treating patients with severe forms of AD is generally challenging for dermatologists. Here, we describe a case of tralokinumab-related facial redness in a patient who had a good response to the drug previously. Idioma: Inglés DOI: 10.1111/ijd.17231 Año: 2024 Publicado en: INTERNATIONAL JOURNAL OF DERMATOLOGY 63, 11 (2024), 1605-1606 ISSN: 0011-9059 Tipo y forma: Article (Published version) Área (Departamento): Área Dermatología (Dpto. Medicina, Psiqu. y Derm.)
Exportado de SIDERAL (2024-12-20-12:05:37)